Angel M R Schols1, Robert T A Willemsen1, Tobias N Bonten2, Martijn H Rutten3, Patricia M Stassen4, Bas L J H Kietselaer5, Geert-Jan Dinant1, Jochen W L Cals6. 1. Department of Family Medicine, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maas-tricht, The Netherlands. 2. Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands. 3. Radboud Institute for Health Sciences, Scientific Center for Quality of Healthcare (IQ Healthcare), Radboud University Medical Center, Nijmegen, The Netherlands. 4. Department of Internal Medicine, Division of General Medicine, Section of Acute Medicine, Care and Public Health Research Institute (CAPHRI), Maastricht University Medical Center, Maastricht, The Netherlands. 5. Department of Cardiology, Zuyderland Medical Center, Heerlen and Sittard, The Netherlands. 6. Department of Family Medicine, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maas-tricht, The Netherlands j.cals@maastrichtuniversity.nl.
Abstract
PURPOSE: Our primary objective was to evaluate the Marburg Heart Score (MHS), a clinical decision rule, or to develop an adapted clinical decision rule for family physicians (FPs) to safely rule out acute coronary syndrome (ACS) in patients referred to secondary care for suspected ACS. The secondary objective was to evaluate the feasibility of using the flash-mob method, an innovative study design, for large-scale research in family medicine. METHODS: In this 2-week, nationwide, prospective, observational, flash-mob study, FPs collected data on possible ACS predictors and assessed ACS probability (on a scale of 1-10) in patients referred to secondary care for suspected ACS. RESULTS: We collected data for 258 patients in 2 weeks by mobilizing approximately 1 in 5 FPs throughout the country via ambassadors. A final diagnosis was obtained for 243 patients (94.2%), of whom 45 (18.5%) received a diagnosis of ACS. Sex, sex-adjusted age, and ischemic changes on electrocardiography were significantly associated with ACS. The sensitivity of the MHS (cut-off ≤2) was 75.0%, specificity was 44.0%, positive predictive value was 24.3%, and negative predictive value was 88.0%. For the FP assessment (cut-off ≤5), these test characteristics were 86.7%, 41.4%, 25.2%, and 93.2%, respectively. CONCLUSIONS: For patients referred to emergency care, ACS could not be safely ruled out using the MHS or FP clinical assessment. The flash-mob study design may be a feasible alternative research method to investigate relatively simple, clinically relevant research questions in family medicine on a large scale and over a relatively short time frame.
PURPOSE: Our primary objective was to evaluate the Marburg Heart Score (MHS), a clinical decision rule, or to develop an adapted clinical decision rule for family physicians (FPs) to safely rule out acute coronary syndrome (ACS) in patients referred to secondary care for suspected ACS. The secondary objective was to evaluate the feasibility of using the flash-mob method, an innovative study design, for large-scale research in family medicine. METHODS: In this 2-week, nationwide, prospective, observational, flash-mob study, FPs collected data on possible ACS predictors and assessed ACS probability (on a scale of 1-10) in patients referred to secondary care for suspected ACS. RESULTS: We collected data for 258 patients in 2 weeks by mobilizing approximately 1 in 5 FPs throughout the country via ambassadors. A final diagnosis was obtained for 243 patients (94.2%), of whom 45 (18.5%) received a diagnosis of ACS. Sex, sex-adjusted age, and ischemic changes on electrocardiography were significantly associated with ACS. The sensitivity of the MHS (cut-off ≤2) was 75.0%, specificity was 44.0%, positive predictive value was 24.3%, and negative predictive value was 88.0%. For the FP assessment (cut-off ≤5), these test characteristics were 86.7%, 41.4%, 25.2%, and 93.2%, respectively. CONCLUSIONS: For patients referred to emergency care, ACS could not be safely ruled out using the MHS or FP clinical assessment. The flash-mob study design may be a feasible alternative research method to investigate relatively simple, clinically relevant research questions in family medicine on a large scale and over a relatively short time frame.
Authors: B E Backus; A J Six; J C Kelder; M A R Bosschaert; E G Mast; A Mosterd; R F Veldkamp; A J Wardeh; R Tio; R Braam; S H J Monnink; R van Tooren; T P Mast; F van den Akker; M J M Cramer; J M Poldervaart; A W Hoes; P A Doevendans Journal: Int J Cardiol Date: 2013-03-07 Impact factor: 4.164
Authors: M H E Bruins Slot; F H Rutten; G J M G van der Heijden; G J Geersing; J F C Glatz; A W Hoes Journal: Fam Pract Date: 2011-01-14 Impact factor: 2.267
Authors: Barbra E Backus; A Jacob Six; Johannes C Kelder; Thomas P Mast; Frederieke van den Akker; E Gijis Mast; Stefan H J Monnink; Rob M van Tooren; Pieter A F M Doevendans Journal: Crit Pathw Cardiol Date: 2010-09
Authors: S Nilsson; M Scheike; D Engblom; L G Karlsson; S Mölstad; I Akerlind; K Ortoft; E Nylander Journal: Br J Gen Pract Date: 2003-05 Impact factor: 5.386
Authors: Jelmer Alsma; Jan L C M van Saase; Prabath W B Nanayakkara; W E M Ineke Schouten; Anique Baten; Martijn P Bauer; Frits Holleman; Jack J M Ligtenberg; Patricia M Stassen; Karin H A H Kaasjager; Harm R Haak; Frank H Bosch; Stephanie C E Schuit Journal: Chest Date: 2016-12-07 Impact factor: 9.410
Authors: R E Harskamp; M Kleton; I H Smits; A Manten; J C L Himmelreich; H C P M van Weert; R P Rietveld; W A M Lucassen Journal: Neth Heart J Date: 2021-01-06 Impact factor: 2.380
Authors: Jesse P A Demandt; Jo M Zelis; Arjan Koks; Geert H J M Smits; Pim van der Harst; Pim A L Tonino; Lukas R C Dekker; Marcel van Het Veer; Pieter-Jan Vlaar Journal: BMJ Open Date: 2022-04-05 Impact factor: 2.692
Authors: Sietske C van Nassau; Marinde J Bond; Ilva Scheerman; Jesper van Breeschoten; Rob Kessels; Liselot B Valkenburg-van Iersel; Henk M Verheul; Tineke E Buffart; Leonie J Mekenkamp; Valery E Lemmens; Miriam Koopman; Guus M Bol Journal: JAMA Netw Open Date: 2021-09-01